Simplex Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-943
Closed -$4.95M 9512
2020
Q3
$4.95M Buy
943
+909
+2,674% +$37.6K 0.01% 876
2020
Q2
$113K Buy
34
+25
+278% +$796 ﹤0.01% 4680
2020
Q1
$24K Sell
9
-26
-74% -$724 ﹤0.01% 5816
2019
Q4
$69K Buy
35
+5
+17% +$80 ﹤0.01% 4902
2019
Q3
$38K Sell
30
-43
-59% -$519 ﹤0.01% 5294
2019
Q2
$90K Sell
73
-65
-47% -$863 ﹤0.01% 4303
2019
Q1
$200K Buy
138
+132
+2,200% +$1.69K ﹤0.01% 3613
2018
Q4
$6K Sell
6
-21
-78% -$292 ﹤0.01% 6173
2018
Q3
$71K Sell
27
-39
-59% -$1.05K ﹤0.01% 4807
2018
Q2
$134K Buy
+66
New +$1.42K ﹤0.01% 3953
2018
Q1
Sell
-13
Closed -$1K 7235
2017
Q4
$1K Buy
+13
New +$176 ﹤0.01% 5778
2017
Q3
Sell
-40
Closed -$4K 6992
2017
Q2
$4K Sell
40
-35
-47% -$533 ﹤0.01% 4854
2017
Q1
$4K Sell
75
-57
-43% -$893 ﹤0.01% 4877
2016
Q4
$23K Sell
132
-89
-40% -$1.18K ﹤0.01% 2928
2016
Q3
$8K Buy
221
+111
+101% +$1.3K ﹤0.01% 3877
2016
Q2
$1K Buy
+110
New +$1.14K ﹤0.01% 5556
2015
Q4
Sell
-25
Closed -$5K 6450
2015
Q3
$5K Buy
25
+17
+213% +$348 ﹤0.01% 4036
2015
Q2
$3K Sell
8
-24
-75% -$478 ﹤0.01% 4151
2015
Q1
$3K Sell
32
-54
-63% -$702 ﹤0.01% 3955
2014
Q4
$5K Buy
+86
New +$983 ﹤0.01% 3150

Simplex Trading's MNTA Position: Q3 2020 in Review

Simplex Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 323 shares — an estimated $13.4K sold.

Simplex Trading first reported a position in MNTA in Q4 2014 and held it in 13 quarters. The position peaked at $270K in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Simplex Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Simplex Trading sold 323 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13.4K.
  • Simplex Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • Simplex Trading's Momenta Pharmaceuticals, Inc. position peaked at $270K in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.